Información del producto
NMNAT1 antibody
Información adicional
Size
100µg
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Applications
ELISA, WB, IHC
Target
NMNAT1
Research Area
Metabolism
Form
liquid
Recomended Dilution
IHC: 1:20-1:200
WB: 1:500-1:2000
WB: 1:500-1:2000
Type Clonality
polyclonal
Immunogen
nicotinamide nucleotide adenylyltransferase 1
Minimum Purity
≥95% as determined by SDS-PAGE
Synonyms
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1)|Nicotinamide-nucleotide adenylyltransferase 1 (NMN adenylyltransferase 1)|Nicotinate-nucleotide adenylyltransferase 1 (NaMN adenylyltransferase 1)|NMNAT1|NMN
Host
Rabbit
UniProt ID
Q9HAN9
Gene ID
64802
Purification
Immunogen affinity purified
Iso type
IgG
Reactivity
Human
Observed MW
32 kDa
Background
Catalyzes the formation of NAD(+) from nicotinamide mononucleotide(NMN) and ATP(PubMed:17402747). Can also use the deamidated form
nicotinic acid mononucleotide(NaMN) as substrate with the same efficiency(PubMed:17402747). Can use triazofurin monophosphate(TrMP) as substrate(PubMed:17402747). Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+)(PubMed:1
nicotinic acid mononucleotide(NaMN) as substrate with the same efficiency(PubMed:17402747). Can use triazofurin monophosphate(TrMP) as substrate(PubMed:17402747). Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+)(PubMed:1